Huber Capital Management LLC Eli Lilly & CO Transaction History

Huber Capital Management LLC

$426 Million
Q2 2024

A detailed history of Huber Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Huber Capital Management LLC holds 22,437 shares of LLY stock, worth $19.7 Million. This represents 4.77% of its overall portfolio holdings.

Number of Shares

22,437

Previous 23,037 2.6%

Holding current value

$19.7 Million

Previous $17.9 Million 13.35%

% of portfolio

4.77%

Previous 4.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $434,922 - $545,424	-600 Reduced 2.6%	22,437 $20.3 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $118,440 - $158,456	200 Added 0.88%	23,037 $17.9 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $52,519 - $61,913	-100 Reduced 0.44%	22,837 $13.3 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $217,350 - $299,650	500 Added 2.23%	22,937 $12.3 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $403,819 - $474,266	-1,300 Reduced 5.48%	22,437 $7.71 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $1.22 Million - $1.42 Million	-3,800 Reduced 13.8%	23,737 $8.68 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $473,841 - $556,359	-1,700 Reduced 5.81%	27,537 $8.93 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $258,159 - $320,826	-1,100 Reduced 3.63%	29,237 $8.37 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $1.2 Million - $1.49 Million	-5,322 Reduced 14.92%	30,337 $8.38 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $221,600 - $272,710	-1,000 Reduced 2.73%	35,659 $8.24 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $36,110 - $46,708	-200 Reduced 0.54%	36,659 $8.41 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $2.71 Million - $3.58 Million	-20,763 Reduced 36.03%	36,859 $6.22 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $6.46 Million - $7.48 Million	-44,200 Reduced 43.41%	57,622 $8.53 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $5.12 Million - $6.16 Million	-37,500 Reduced 26.92%	101,822 $16.7 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $1.28 Million - $1.59 Million	-12,000 Reduced 7.93%	139,322 $18.3 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2.37 Million - $2.58 Million	22,200 Added 17.19%	151,322 $16.9 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $1.15 Million - $1.34 Million	-10,400 Reduced 7.45%	129,122 $14.3 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $11.9 Million - $14 Million	-107,000 Reduced 43.4%	139,522 $18.1 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $9.25 Million - $10.4 Million	-87,300 Reduced 26.15%	246,522 $28.5 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $5.06 Million - $5.81 Million	-66,874 Reduced 16.69%	333,822 $28.5 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $798,796 - $942,926	-10,764 Reduced 2.62%	400,696 $31 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $1.12 Million - $1.2 Million	13,700 Added 3.44%	411,460 $34.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $30.7 Million - $34 Million	397,760	397,760 $34 Million

Others Institutions Holding LLY

# of Institutions

3,872

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $834B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huber Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Huber Capital Management LLC with notifications on news.

Account

Huber Capital Management LLC Eli Lilly & CO Transaction History